NFKB1 and non-small cell lung carcinoma: As part of berberine’s anti-inflammatory mechanisms, it suppressed multiple pathways in NSCLC including NF-κB/COX2, PI3K/AKT, vascular endothelial growth factor (VEGF)/HIF1A, and MERK/ERK [152].